CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Grant or award Director acquired 3,125 shares (grant or award)
- 4 Grant or award Director acquired 3,125 shares (grant or award)
- 4 Grant or award Director acquired 3,125 shares (grant or award)
- 4 Grant or award Director acquired 3,125 shares (grant or award)
- 4 Grant or award Director acquired 3,125 shares (grant or award)
- 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $26.22 ($78,671)
- 4 Open-market sale VP, Research sold 4,112 shares at $25.50 ($104,856)
- 4 Open-market sale President and CFO sold 3,100 shares at an average $24.44 ($75,763)
- 4 Open-market sale Chief Executive Officer sold 11,000 shares at an average $23.91 ($262,990)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP, Research sold 888 shares at $25.80 ($22,914)
- 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $25.00 ($75,000)
- 4 Open-market sale Chief Operating Officer sold 2,800 shares at $23.98 ($67,130)
- 4 Open-market sale President and CFO sold 3,100 shares at $24.05 ($74,542)
- 4 Open-market sale Chief Executive Officer sold 11,000 shares at $23.98 ($263,766)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale VP, Research sold 5,000 shares at $25.59 ($127,950)
- 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $25.00 ($75,000)
- 4 Open-market sale Chief Executive Officer sold 22,000 shares at an average $24.82 ($546,143)
- 4 Open-market sale President and CFO sold 3,100 shares at $26.13 ($80,993)
Page 15 of 22 · 421 filings